ZNTL
Zentalis Pharmaceuticals, Inc. · Healthcare
Director Cam Gallagher sold $1.0M of Zentalis Pharmaceuticals, Inc.
Sold$1,034,260
$55.99Price
18,473Shares
−3%Stake
What ZNTL did after the filing
- The stock from Thu, Feb 4 open, $41.21
- +6.6%
- S&P 500, same days
- +2.0%
Measured over 30 trading days, to the Mar 19 close.
Traded Thu, Dec 24. Filed Wed, Feb 3. Returns use the Feb 4 open and the Mar 19 close. Not investment advice.